Literature DB >> 1575793

Hereditary dysfunction of the third component of complement associated with a systemic lupus erythematosus-like syndrome and meningococcal meningitis.

U R Nilsson1, B Nilsson, K E Storm, G Sjölin-Forsberg, R Hällgren.   

Abstract

OBJECTIVE: We describe a dysfunction of C3 in a patient with a systemic lupus erythematosus (SLE)-like syndrome. Alternative pathway complement function was absent, but classical pathway complement function was partially intact.
METHODS: We used functional, preparative, and immunochemical techniques in the study.
RESULTS: The patient's C3 proved normally susceptible to trypsin proteolysis and partially resistant to classical pathway, but completely resistant to alternative pathway, convertase-dependent cleavage.
CONCLUSION: The dysfunction, thus, was caused by a failure of C3 to interact with the C3 convertases, rather than by a lack of a proteinase-sensitive cleavage site in the deficient protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575793     DOI: 10.1002/art.1780350516

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  6 in total

1.  Homozygous hereditary C3 deficiency due to a premature stop codon.

Authors:  Edimara Da Silva Reis; Gisele Vanessa Baracho; Adriana Sousa Lima; Chuck S Farah; Lourdes Isaac
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

Review 2.  Complement deficiency and immune complex disease.

Authors:  K A Davies; J A Schifferli; M J Walport
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Rare loss-of-function mutation in complement component C3 provides insight into molecular and pathophysiological determinants of complement activity.

Authors:  Georgia Sfyroera; Daniel Ricklin; Edimara S Reis; Hui Chen; Emilia L Wu; Yiannis N Kaznessis; Kristina N Ekdahl; Bo Nilsson; John D Lambris
Journal:  J Immunol       Date:  2015-02-23       Impact factor: 5.422

4.  Inhibition of complement activation on a model biomaterial surface by streptococcal M protein-derived peptides.

Authors:  Anna E Engberg; Kerstin Sandholm; Fredrik Bexborn; Jenny Persson; Bo Nilsson; Gunnar Lindahl; Kristina N Ekdahl
Journal:  Biomaterials       Date:  2009-01-25       Impact factor: 12.479

5.  Reconstitution of the alternative pathway of complement by plasma infusions given to a patient with an SLE-like syndrome associated with a hereditary C3 dysfunction.

Authors:  B Nilsson; U R Nilsson; A Karlsson-Parra; G Sjölin-Forsberg; R Hällgren
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

6.  Use of serum or buffer-changed EDTA-plasma in a rapid, inexpensive, and easy-to-perform hemolytic complement assay for differential diagnosis of systemic lupus erythematosus and monitoring of patients with the disease.

Authors:  Kristina N Ekdahl; Dan Norberg; Anders A Bengtsson; Gunnar Sturfelt; Ulf R Nilsson; Bo Nilsson
Journal:  Clin Vaccine Immunol       Date:  2007-03-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.